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Background: Fine-needle aspiration (FNA) has been widely
recognized as an important modality in assessment of salivary
gland neoplasms, and specimens are often processed as con-
ventional smears. We conducted the current study to evaluate
the diagnostic utility of ThinPrep preparation as an alterna-
tive method for assessment of salivary gland neoplasms.
Methods: A computer SNOMED search from the pathology
database at our institution between July 1999 and June 2012
was conducted to identify FNA cytology specimens of salivary
gland lesions for which follow-up surgical specimens revealed
neoplasms. The FNA specimens were divided into two
cohorts: one cohort consisted solely of the specimens in
which all needle passes were collected into CytoLyt solution
and only ThinPrep slides were prepared; and the other
cohort included the specimens prepared with conventional
smears. Diagnostic performance of the two cohorts was
compared.
Results: Nondiagnostic rate of ThinPrep preparation was signifi-
cantly higher than that of conventional smears (40% vs.18%; P
<0.001). Among the diagnostic specimens, although more inde-
terminate diagnoses were generated in ThinPrep preparation
compared to conventional smears (40% vs. 26%; P 5 0.024),
absolute cytohistologic concordant rate for the positive cases
(type of neoplasms specified) is similar between the two prepa-
rations (80% vs. 86%; P 5 0.354). Furthermore, there is no sig-
nificant difference in rate of accurate diagnosis (correct typing
of benign versus malignant neoplasm) between the two prepara-
tions (70% vs. 81%; P 5 0.057).
Conclusions: ThinPrep may be considered as another practical
method of specimen preparation in the assessment of salivary
gland neoplasms, particularly when FNA is performed without
immediate assistance from cytology. Diagn. Cytopathol.
2015;43:98–104. VC 2014 Wiley Periodicals, Inc.
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Fine-needle aspiration (FNA) is a useful triage tool in the
assessment of salivary gland lesions; it aims to distinguish
neoplastic from non-neoplastic lesions. Furthermore, it
may make a distinction between benign and malignant
neoplasms as well as between low-grade and high-grade
neoplasms. FNA cytology specimens are commonly proc-
essed as multiple conventional smears which are stained
with Giemsa, Diff-Quik and/or Papanicolaou stains. Using
conventional smear preparation, diagnostic sensitivity
ranges from 63% to 93% and specificity ranges from 90%
to 100% while achieving 86% to 97% diagnostic
accuracy.1–7
ThinPrep (Cytyc Corporation [now HologicVR ], Marl-
borough, MA) was introduced into our cytology practice
as an alternative method for processing salivary gland
FNA specimens more than 10 years ago. Generally, Thin-
Prep preparation has a number of advantages over con-
ventional smear preparation, such as easier submission of
the specimen, that is directly rinsed in the CytoLytVR col-
lecting medium (Cytyc Corporation [now Hologic], Marl-
borough, MA), fewer numbers of slides examined, well-
preserved nuclear details, and a cleaner background. On
the other hand, for each specimen only one ThinPrep
slide is routinely prepared, and it represents a random
sample obtained from multiple needle passes. ThinPrep
preparation produces cytological artifacts including appa-
rent discohesion with smaller cellular clusters, fragmented
cellular sheets, more single cells, and cellular shrinkage.8
These artifacts could possibly cause cytological
misinterpretation.
Department of Pathology, The University of Michigan, Ann Arbor,
Michigan
*Correspondence to: Xin Jing, M.D., Department of Pathology, Uni-
versity of Michigan, 1500 E. Medical Center Drive, 2G332 UH, Ann
Arbor, MI 48109-0054, USA. E-mail: xinjing@med.umich.edu
Received 24 April 2013; Revised 19 March 2014; Accepted 11 June
2014
DOI: 10.1002/dc.23188
Published online 27 June 2014 in Wiley Online Library (wileyonline-
library.com).
98 Diagnostic Cytopathology, Vol. 43, No 2 VC 2014 WILEY PERIODICALS, INC.
In the current study, we evaluated the diagnostic yield
of ThinPrep preparation as an alternative specimen proc-
essing method in the assessment of FNA biopsy of sali-
vary gland neoplasms as compared to conventional smear
preparation.
Methods
A computer SNOMED search from the pathology data-
base at our institution between July 1999 and June 2012
was conducted to identify FNA cytology specimens of
salivary gland lesions which were followed by surgical
management and histologic diagnoses of salivary gland
neoplasms were then established. The FNA specimens
were divided into two cohorts: one cohort consisted solely
of the specimens in which all needle passes were col-
lected into the CytoLyt solution and only Papanicolaou-
stained ThinPrep slides were then prepared (1 slide/speci-
men); and the other cohort included the specimens pre-
pared with conventional smears which were stained with
both Diff-Quik and Papanicolaou stains.
All FNA procedures were performed with or without
ultrasound guidance by otolaryngologists, radiologists, or
cytopathologists. The size of needles ranged from 21 to
26 gauge, and the salivary gland masses ranged from
0.5 cm to 15 cm. A total of two to seven passes were per-
formed for each FNA procedure, at the discretion of the
performing physician.
The original cytologic diagnosis was recorded for each
of the FNA specimens. Since the study only included
cases with histology-confirmed salivary gland neoplasms,
FNA cytologic diagnoses were divided into non-
diagnostic, positive and indeterminate categories. The
diagnosis was designated as “non-diagnostic” when origi-
nal cytology report indicated the specimen being unsatis-
factory, or only containing cyst contents or normal
salivary gland elements. The diagnosis was considered
“positive” when the type of neoplasm was specified
whereas the “indeterminate” category referred to cases in
which a descriptive interpretation was rendered with or
without differential diagnoses. The corresponding histo-
logic diagnosis was also documented for each diagnostic
case, and cyto-histologic correlation was then performed.
Absolute cyto-histologic concordance was achieved when
the cytologic diagnosis of a specific neoplasm was con-
firmed by the follow-up histology. A cytologic diagnosis
was considered accurate if the neoplasm was correctly
designated as either benign or malignant.
The nondiagnostic rate, rate of indeterminate diagnosis,
absolute cyto-histologic concordant rate, and rate of accu-
rate diagnosis were calculated for both ThinPrep and con-
ventional preparations. The parameters were then
compared between the two cohorts by using v2 test with
the help of the SigmaStat.3.5 program (Systat Software,
Inc.). The level of difference was considered statistically
significant when P value 0.05.
To document the cytomorphological features of Thin-
Prep preparation, the available ThinPrep slides and the
corresponding histology slides were retrospectively
reviewed.
Results
The study included a total of 178 ThinPrep and 191 con-
ventional specimens. Of the 178 ThinPrep specimens, 72
(40%) were non-diagnostic while 35 out of 191 (18%)
conventional specimens were nondiagnostic. The differ-
ence in non-diagnostic rate is significantly different
(v25 20.84, df5 1; P <0.001).
Among the 106 diagnostic ThinPrep specimens, 64 had
a “positive” cytologic diagnosis with the type of neo-
plasm specified, including 44 benign and 20 malignant
Table I. Specific Type of Neoplasms Diagnosed by ThinPrep Preparation and the Corresponding Histology Diagnosis
Cytology diagnosis N Histology-proven, N (%) Other histology diagnoses (n)
Benign
Pleomorphic adenoma 27 25 (93) Adenoid cystic carcinoma (1), neuro-
endocrine tumor (1)
Warthin’s tumor 17 14 (82) Pleomorphic adenoma (1), acinic cell
carcinoma (1), mucoepidermoid
carcinoma (1)
Subtotal for benign 44 39 (89) —
Malignant
Acinic cell carcinoma 7 6 (86) Warthin’s tumor (1)
Adenoid cystic carcinoma 1 1 (100) —
Mucoepidermoid carcinoma 11 4 (36) Pleomorphic adenoma (1), canalicu-
lar adenoma (1), salivary duct car-
cinoma (3), squamous cell
carcinoma (2)
Myoepithelial carcinoma 1 1 (100) —
Subtotal for malignant 20 12 (60) —
Total (%) 64 51 (80) —
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neoplasms (Table I). The corresponding histology con-
firmed absolute cyto-histologic concordance in 39 of 44
(89%) benign and 12 of 20 (60%) malignant cases,
respectively. The combined rate of cyto-histologic con-
cordance reached 80% (51/64). Although ThinPrep
detected neoplasms in the remaining 13 specimens, the
type of the neoplasms was not correctly identified. In this
regard, acinic cell carcinoma was misinterpreted as War-
thin’s tumor and vice versa; mucoepidermoid carcinoma
was misinterpreted as pleomorphic adenoma and vice
versa; Warthin’s tumor was misdiagnosed as pleomorphic
adenoma or low grade mucoepidermoid carcinoma; pleo-
morphic adenoma was misdiagnosed as adenoid cystic
carcinoma or neuroendocrine tumor; mucoepidermoid car-
cinoma was misdiagnosed as salivary duct carcinoma,
squamous cell carcinoma, and canalicular adenoma.
The remaining 42 (40%) diagnostic ThinPrep specimens
were classified as “indeterminate.” Follow-up histology
confirmed the presence of one neoplasm/malignancy
included in the differential diagnosis in 57% (24 of 42) of
the cases. Cytologic under-interpretation occurred in three
(7%) cases whereas over-interpretation occurred in seven
(17%) cases. With regard to the latter, four cases showed
potential of false positive interpretation of neoplasm as dif-
ferential diagnoses included Warthin’s tumor, and the
follow-up histology revealed no neoplasm (Table II).
Accurate cytologic diagnosis (correct typing of
benign versus malignant neoplasm) was rendered in 57
Table II. ThinPrep Specimens with Indeterminate Interpretations and the Follow-Up Histology Diagnoses
Case Cytologic differential diagnoses Histology diagnosis
1 Pleomorphic adenoma vs. PLGA Pleomorphic adenoma
2 Pleomorphic adenoma vs. mucoepidermoid carcinoma Pleomorphic adenoma
3 Pleomorphic adenoma vs. mucoepidermoid carcinoma Pleomorphic adenoma
4 Pleomorphic adenoma vs. mucoepidermoid carcinoma Pleomorphic adenoma
5a Pleomorphic adenoma vs. myoepithelioma Pleomorphic adenoma
6 Pleomorphic adenoma vs. PLGA Adenoid cystic carcinoma
7b Pleomorphic adenoma vs. trabecular adenoma Adenoid cystic carcinoma
8 Pleomorphic adenoma vs. adenoid cystic carcinoma Adenoid cystic carcinoma
9b Pleomorphic adenoma vs. myoepithelioma Adenoid cystic carcinoma
10a Warthin’s tumor vs. oncocytic metaplasia Warthin’s tumor
11a Warthin’s tumor vs. sialadenitis Warthin’s tumor
12a Warthin’s tumor vs. sialadenitis Warthin’s tumor
13 Warthin’s tumor vs. mucoepidermoid carcinoma Warthin’s tumor
14 Warthin’s tumor vs. mucoepidermoid carcinoma Warthin’s tumor
15a Warthin’s tumor vs. oncocytoma Warthin’s tumor
16 Warthin’s tumor vs. mucoepidermoid carcinoma Squamous cell carcinoma
17 Warthin’s tumor vs. mucoepidermoid carcinoma Squamous cell carcinoma
18 Warthin’s tumor vs. adenocarcinoma Salivary duct carcinoma
19 Warthin’s tumor vs. malignant neoplasm PDC
20 Warthin’s tumor vs. lymphoma Follicular lymphoma
21b Warthin’s tumor vs. lymph node MALT lymphoma
22c Warthin’s tumor vs. oncocytoma Oncocytic cyst
23c Warthin’s tumor vs. oncocytoma Bronchial cleft cyst
24c Warthin’s tumor vs. reactive Negative for neoplasm
25c Warthin’s tumor vs. reactive Negative for neoplasm
26c Acinic cell carcinoma vs. adenocarcinoma Pleomorphic adenoma
27a Adenoid cystic carcinoma vs. basal cell carcinoma Adenoid cystic carcinoma
28a Adenoid cystic carcinoma vs. basal cell carcinoma Adenoid cystic carcinoma
29c adenoid cystic carcinoma vs. PLGADC Myoepithelioma
30a Low grade neoplasm Pleomorphic adenoma
31a Low grade neoplasm Warthin’s tumor
32 Low grade neoplasm Adenoid cystic carcinoma
33 Low grade neoplasm PLGA
34c Carcinoma ex PA vs. mucoepidermoid carcinoma Pleomorphic adenoma
35a Mucoepidermoid carcinoma vs. skin tumor Mucoepidermoid carcinoma
36a Mucoepidermoid carcinoma vs. squamous cell carcinoma Mucoepidermoid carcinoma
37a Mucoepidermoid carcinoma vs. squamous cell carcinoma Squamous cell carcinoma
38a Mucoepidermoid carcinoma vs. squamous cell carcinoma Squamous cell carcinoma
39a Mucoepidermoid carcinoma vs. squamous cell carcinoma Squamous cell carcinoma
40a Mucoepidermoid carcinoma vs. squamous cell carcinoma Salivary duct carcinoma
41a Mucoepidermoid carcinoma vs. squamous cell carcinoma PDC
42a Mucoepidermoid carcinoma vs. adenocarcinoma Carcinoma ex PA
aCases with accurate cytologic diagnosis (correct typing of benign vs. malignant neoplasm).
bCases with cytologic under-interpretation.
cCases with cytologic over-interpretation.
PLGA: polymorphous low grade adenocarcinoma; carcinoma ex PA: carcinoma ex pleomorphic adenoma; PDC: poorly differentiated carcinoma.
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of 64 “positive” cases and 17 of 42 “indeterminate”
cases. Overall, an accurate cytologic diagnosis was ren-
dered in 70% (74 of 106) of all diagnostic ThinPrep
specimens.
Among the 156 diagnostic conventional specimens, 116
had a “positive” cytologic diagnosis with the specific type
of neoplasm, including 89 benign and 27 malignant neo-
plasms (Table III). The corresponding histology con-
firmed absolute cyto-histologic concordance in 77 of 89
(86%) benign and 23 of 27 (85%) malignant cases,
respectively. The combined rate of cyto-histologic con-
cordance reached 86% (100 of 116).
The remaining 40 (26%) diagnostic conventional speci-
mens were classified as “indeterminate.” As can be seen
in Table IV, follow-up histology confirmed the presence
of one neoplasm/malignancy included in the differential
diagnosis in 55% (22 of 40) of the cases. Cytologic
under-interpretation occurred in one (2%) case whereas
cytologic over-interpretation occurred in two (5%) cases.
Accurate cytologic diagnosis was rendered in 106 of
116 “positive” cases and 20 of 40 “indeterminate” cases.
Overall rate of accurate diagnosis reached 81% (126 of
156).
Table V summarizes the result of statistical analysis of
the diagnostic performance of ThinPrep preparation in
comparison to conventional smear preparation.
Both cytology and the corresponding histology slides
were available for retrospective review in 71 cases with
ThinPrep preparation. The cytomorphologic features dem-
onstrated by ThinPrep preparation are summarized in
Table VI.
Discussions
FNA is a simple and well-tolerated diagnostic method
which provides a tissue diagnosis compared to imaging
studies such as MRI. FNA has an impact on management
and treatment of salivary gland neoplasms in terms of
preoperative patient counseling, better surgical planning,
and better selection of surgery candidates.4
The advantages and disadvantages of utilizing ThinPrep
technique for assessment of non-gynecological specimens
have been previously described.8 We found only two pub-
lished studies in the English literature which compared
diagnostic accuracy of ThinPrep preparation with that of
conventional smear preparation for salivary gland
FNA.9,10 These two former studies included 58 and 40
cases, respectively. Both studies used a split-sample tech-
nique in which conventional smears were prepared first
and then a ThinPrep slide was prepared from fixative
solution containing residual needle rinses. We report the
first study in which diagnostic performance was evaluated
for non-split-sample ThinPrep preparation. Accordingly,
all needle passes were dedicated to the Cytolyt solution
from that one ThinPrep slide was prepared for each speci-
men. Our data demonstrates that in comparison to con-
ventional smear preparation, ThinPrep preparation may
provide compatible cyto-histologic concordant rate for the
positive cases (type of neoplasms specified) and overall
rate of accurate diagnosis (correct typing of benign versus
malignant neoplasm).
Similar to the previously reported,10 ThinPrep prepara-
tion in the current study had a higher non-diagnostic rate
than that of conventional smear preparation. The higher
non-diagnostic rate seemed to be related to sampling
issues rather than misinterpretation as the original report
indicated the non-diagnostic ThinPrep preparations being
pauci-cellular, containing cyst contents or normal salivary
gland elements. It is noteworthy to mention that the con-
ventional smears in the current study were prepared by
the cytology team and a rapid on-site evaluation (ROSE)
Table III. Specific Type of Neoplasms Diagnosed by Conventional Smears and the Corresponding Histology Diagnosis
Cytology diagnosis N Histology-proven, N (%) Other histology diagnoses(n)
Benign
Pleomorphic adenoma 75 67 (89) Non-neoplastic (2), Warthin’s tumor (2), basal cell adenoma (1), myoepithelioma (1),
mucoepidermoid carcinoma (1), chondrosarcoma (1)
Warthin’s tumor 12 10 (83) Pleomorphic adenoma (1), non-neoplastic (1)
Basal cell adenoma 1 0 Epithelial myoepithelial carcinoma (1)
Myoepithelioma 1 0 Pleomorphic adenoma (1)
Subtotal for benign 89 77(86) —
Malignant
PLGA 1 (100) —
Acinic cell carcinoma 5 3 (60) Warthin’s tumor (1), pleomorphic adenoma (1)
Adenoid cystic carcinoma 4 4 (100) —
Carcinoma ex PA 1 0 Pleomorphic adenoma (1)
Mucoepidermoid carcinoma 14 14 13 (93) Squamous cell carcinoma (1)
Salivary ductal carcinoma 1 1 (100) —
Squamous cell carcinoma 1 1 (100) —
Subtotal for malignant 27 23 (85) —
Total (%) 116 100 (86) —
PLGA: polymorphous low grade adenocarcinoma; carcinoma ex PA: carcinoma ex pleomorphic adenoma.
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was provided at the time of the FNA procedures. How-
ever, assessment of benefit of ROSE for FNA diagnosis
of salivary gland neoplasms is beyond the scope of this
study.
One of the aforementioned studies using split-sample
technique considered a diagnosis accurate if it was cor-
rectly designated as either benign or malignant. The
authors reported that the rate of accurate diagnosis could
reached up to 60% in cellular specimens using ThinPrep
preparation, and ThinPrep correctly identified 63% (25 of
40) of the pleomorphic adenomas.10 Of the 64 cases in
our study with a specific diagnosis of either benign or
malignant, an accurate diagnosis was established in 80%
(51 of 64) of the cases, and ThinPrep correctly classified
93% (25 of 27) of the pleomorphic adenomas. The differ-
ence in precision between the current and former studies
may be attributed to bias of the split-sample technique of
the latter.
While evaluating the diagnostic yield of FNA cytology
for salivary gland lesions, the vast majority of the previ-
ous studies, with one exception,10 incorporated cases with
an “indeterminate” diagnosis into the “positive” category.
Given the bias due to handling indeterminate results in
this manner, Schmidt et al have recommended subclassifi-
cation of cytology results into categories of positive, neg-
ative, indeterminate, and inadequate; as well as separation
of neoplasm from malignancy while reporting diagnostic
accuracy.11 The current study used a similar approach by
separating the cases with indeterminate cytologic interpre-
tations from the cases with specific diagnoses. For the 64
cases with specific “positive” diagnoses, cyto-histologic
concordance reached 80%, which is comparable to that of
Table IV. Conventional Smear Preparation with Indeterminate Interpretations and the Follow-Up Histology Diagnoses
Case Cytologic differential diagnoses Histology diagnosis
1a Pleomorphic adenoma vs. Warthin’s tumor Acinic cell carcinoma
2 Pleomorphic adenoma vs. adenoid cystic carcinoma Adenoid cystic carcinoma
3b Pleomorphic adenoma vs. myoepithelioma Pleomorphic adenoma
4 Pleomorphic adenoma vs. PLGA High grade carcinoma
5b Pleomorphic adenoma vs. myoepithelioma Pleomorphic adenoma
6b Basal cell adenoma Pleomorphic adenoma
7b Warthin’s tumor vs. lymph node Warthin’s tumor
8b Warthin’s tumor vs. lymph node Warthin’s tumor
9 Warthin’s tumor vs. mucoepidermoid carcinoma Warthin’s tumor
10 Warthin’s tumor vs. mucoepidermoid carcinoma Warthin’s tumor
11 Warthin’s tumor vs. mucoepidermoid carcinoma Mucoepidermoid carcinoma
12b Adenoid cystic carcinoma vs. myoepithelial carcinoma Myoepithelial carcinoma
13b Adenoid cystic carcinoma vs. myoepithelial carcinoma Myoepithelial carcinoma
14 Myoepithelioma vs. myoepithelial carcinoma Squamous cell carcinoma
15 Basaloid neoplasm Squamous cell carcinoma
16 Basaloid neoplasm Basal cell carcinoma
17 Basaloid neoplasm Adenoid cystic carcinoma
18 Basaloid neoplasm Adenoid cystic carcinoma
19 Basaloid neoplasm Adenoid cystic carcinoma
20c Low grade neoplasm vs. mucocele Mucocele
21 Low grade neoplasm Warthin’s tumor
22 Low grade neoplasm Pleomorphic adenoma
23 Low grade neoplasm Basal cell adenoma
24 Low grade neoplasm Mucoepidermoid carcinoma
25 Low grade neoplasm Mucoepidermoid carcinoma
26 Low grade neoplasm Mucoepidermoid carcinoma
27b Low grade carcinoma PLGA
28b High grade carcinoma Squamous cell carcinoma
29c Mucoepidermoid carcinoma vs. cyst Benign cyst
30b Mucoepidermoid carcinoma vs. squamous cell carcinoma Squamous cell carcinoma
31b Mucoepidermoid carcinoma vs. squamous cell carcinoma Squamous cell carcinoma
32b Mucoepidermoid carcinoma vs. squamous cell carcinoma Squamous cell carcinoma
33b Mucoepidermoid carcinoma vs. squamous cell carcinoma Squamous cell carcinoma
34b Mucoepidermoid carcinoma vs. salivary duct carcinoma Salivary ductal carcinoma
35b Mucoepidermoid carcinoma vs. salivary duct carcinoma Squamous cell carcinoma
36b Mucoepidermoid carcinoma vs. salivary duct carcinoma High grade carcinoma
37b High grade neoplasm Salivary duct carcinoma
38b PDC PDC
39b PDC Epithelial myoepithelial ca
40b ADC Salivary duct carcinoma
aCases with cytologic under-interpretation.
bCases with accurate cytologic diagnosis (correct typing of benign vs. malignant neoplasm).
cCases with cytologic over-interpretation.
PLGA: polymorphous low grade adenocarcinoma; carcinoma ex PA: Carcinoma ex pleomorphic adenoma; PDC: poorly differentiated carcinoma.
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conventional smear preparation in the current study
(86%) and the cyto-histologic concordant rate previously
reported by the others (79%).1 One previous study using
conventional smear preparation correctly typed 92% of
pleomorphic adenomas, 75% of Warthin’s tumors, and
33% of malignant neoplasms, suggesting that conven-
tional smear preparation appears to be more reliable for
correctly typing benign than malignant salivary gland
neoplasms.4 We observed the similar finding for ThinPrep
preparation; however, the current study showed that con-
ventional smear preparation correctly typed similar per-
centage of pleomorphic adenoma (89%), Warthin’s
tumors (83%) and malignant neoplasms (85%). Estimat-
ing an accuracy rate for the subpopulations of cases with
specific diagnoses, either benign or malignant is impor-
tant. In this regard, prior to performing a FNA procedure,
otolaryngologists often have a clinical impression that
comes from a CT, MRI or ultrasound image as well as
the overall history of the patient. Pleomorphic adenomas
appear well-circumscribed, with low intensity on T1-
weighted images and high intensity on T2-weighted
images, whereas Warthin’s tumor is homogenous and
enhancing on CT scan because of high mitochondrial
counts. The latter also occurs exclusively in the parotid
gland and is more common in smokers. Cancers are more
invasive on imaging and patient can present with pain or
facial nerve paralysis. FNA may provide a more specific
pre-operative tissue diagnosis that plays an important role
in preoperative patient counseling, better surgical plan-
ning, and better selection of surgery candidates.
The challenges in distinguishing different types of sali-
vary gland neoplasms have been encountered with conven-
tional smear preparation. In this regard, diagnostic
dilemmas on FNA assessment of salivary gland neoplasms
existed not only in differentiating benign neoplasms (i.e.
cellular pleomorphic adenoma, monomorphic adenoma,
Warthin’s tumor) from malignant neoplasms (i.e. polymor-
phous low-grade adenocarcinoma and acinic cell carci-
noma) but also in distinguishing between non-neoplastic
lesions (i.e. chronic sialadenitis with squamous metaplasia,
lymphoepithelial cyst) and neoplasms (i.e. Warthin’s
tumor, oncocytoma, and low grade mucoepidermoid carci-
noma).7 With regard to the diagnostic specimens, ThinPrep
preparation provided more indeterminate diagnoses than
conventional smear preparation. The finding may be related
to attenuation of cytomorphologic features in ThinPrep
compared to conventional smear preparation.
It has been documented that background material such
as the stroma of pleomorphic adenoma may be attenuated
and less conspicuous in ThinPrep preparation.9,10 How-
ever, for reviewers with hands-on, practical experience, it
is not difficult to appreciate the fibrillary stroma in a
majority of the cases. We also found some features which
may be useful to differentiate cellular pleomorphic ade-
noma (with scant or absent stroma) from adenoid cystic
Table V. Diagnostic Performance of ThinPrep Preparation in Compari-











80 86 0.354 (0.860)
Benign 89 86 0.945 (0.005)
Malignant 60 85 0.105 (2.623)
Indeterminate
Rate of indeterminate diagnosis 40 26 0.024 (5.106)
Histology-confirmed
differential diagnosis
57 55 0.978 (0.001)
Overall rate of accurate diagnosis 70 81 0.057 (3.611)
Table VI. Cytomorphologic Features Demonstrated by ThinPrep Preparation
Histologic diagnosis Cytomorphologic features
Pleomorphic adenoma (n 5 25) 75% of the specimens are moderate to hypercellular with well-preserved epithelial cells and
myoepithelial cells; 50% have coexisting fibrillary stroma, and 25% show scant or no stroma.
The remaining 25% of the specimens are hypocellular with accompanying fibrillary stroma.
Warthin’s tumor (n 5 18) 50% of the specimens are moderate to hypercellular with well-preserved oncocytes, lymphocytes,
and amorphous debris in the background. The remaining 50% of the specimens are hypocellular
containing oncocytes and lymphocytes or oncocytes and amorphous debris. The oncocytes are
arranged as single cells or sheets and have granular cytoplasm, round nuclei and distinct nucleoli.
Shrunken nuclei with mild nuclear membrane irregularity may be seen.
Adenoid cystic carcinoma (n 5 6) All specimens are moderate to hypercellular with or without stroma. Some spheres of stroma are present.
The cells appear monotonous and basaloid and are arranged in a ball-like configuration
with a smooth contour.
Acinic cell carcinoma (n 5 4) All specimens are moderate to hypercellular with single cells or sheets of cells. The cells have
vacuolated to granular cytoplasm, round nuclei, and distinct nucleoli. Naked nuclei, lymphocytes,
and amorphous debris appear in 40% of the specimens.
High-grade carcinoma (n 5 13) All specimens are moderate to hypercellular with malignant-looking cells. 50% of the specimens
show necrotic debris in the background.
Myoepithelioma arising in pleomorphic
adenoma (n 5 1)
Cellular specimen with a mixture of epithelial cells, myoepithelial cells, and fibrillary stroma.
Myoepithelial cells are not a prominent component.
Low-grade lymphoma (n 5 1) Cellular specimen with a numerous monotonous population of lymphocytes.
Neuroendocrine tumor (n 5 1) Cellular specimen with a monotonous population of plasmacytoid cells.
Benign (n 5 2) Cellular specimen with many normal acini and rare oncocytes.
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carcinoma; epithelial cells in pleomorphic adenoma
appear as sheets or loose groups compared to the tight ball-
like arrangement with smooth outlines in adenoid cystic carci-
noma. Regarding Warthin’s tumor, it is a diagnostic challenge
to distinguish Warthin tumor from acinic cell carcinoma
when the latter demonstrates naked nuclei, lymphocytes, and
amorphous debris. However, it is not uncommon to appreci-
ate oncocytes with shrunken or crenated nuclei in Warthin’s
tumor whereas cells of acinic cell carcinoma often have
round nuclei and distinct nucleoli. In two of the four cases
that were initially concerning for Warthin’s tumor, the Thin-
Prep slides contained a notable amount of benign salivary
acini in addition to a scant amount of oncocytes. One should
be cautious to avoid over-interpretation of the presence of
oncocytes in such scenarios. It is noteworthy to mention that
it is extremely difficult to make a distinction among high
grade malignant neoplasms, including high-grade mucoepi-
dermoid carcinoma, salivary duct carcinoma, squamous cell
carcinoma, and carcinoma ex pleomorphic adenoma.
Although moderate- to well-differentiated neuroendocrine
tumors rarely occur in salivary glands,12 single or loose
groups of plasmacytoid-looking tumor cells of these neo-
plasms on the ThinPrep slide could be possibly mistaken as
myoepithelial cells in pleomorphic adenoma.
In conclusion, the current study is the first to focus on
the diagnostic utility of non-split-sample ThinPrep prepa-
ration for FNA assessment of salivary gland neoplasms.
Our data demonstrates that ThinPrep may be considered
as another practical method of specimen preparation in
the assessment of salivary gland neoplasms, particularly
when FNA procedure is performed without immediate
assistance from cytology.
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